Gastrointestinal cancers (GCs) are among the most common forms of cancer and account for as much as one-third of all cancer deaths worldwide.
Early diagnosis is an effective way of reducing the mortality associated with GCs, and endoscopic screening has proved to be an excellent approach for detecting potentially malignant tumours.
To extend the benefits of screening programs to as many people as possible, the imaging systems used should be inexpensive to manufacture and operate, yet accurate enough to achieve low miss rates.
To achieve this, scientists have been experimenting with different imaging modalities.
Among them, spatial frequency domain imaging (SFDI) is a promising technique for differentiating between healthy and malignant tissue.
In SFDI, a repeating 2D pattern of light is projected onto a target area.
By examining the intensity of the reflected light patterns, it is possible to derive information about the optical properties of the tissue under investigation, which can reveal the presence of cancerous lesions.
Despite the simplicity and affordability of this imaging modality, however, current SFDI systems are too bulky to fit inside standard endoscopes, limiting their use in GC screening.
Against this backdrop, researchers Jane Crowley and George Gordon from University of Nottingham have recently developed an innovative SFDI device that shows promise for gastrointestinal endoscopy applications.
Their study, published in the Journal of Biomedical Optics, could help make GC screening more widely accessible to the general population.
A major challenge in this study was finding a method to generate the light patterns necessary to perform SFDI in a convenient and cost-effective way.
“Existing systems are not fit for routine endoscopic deployment in the gastrointestinal tract because they either use digital micromirror device-based projectors, which are costly and cannot be sufficiently miniaturized, or use fibre bundles which produce low-quality patterns at a limited set of wavelengths and only record low-resolution images, or use rigid endoscopes that are not flexible enough,” explains Crowley.
To overcome these issues, the researchers designed an ultraminiature SFDI system that uses a custom-made optic fibre bundle as a projector.
The fibre bundle consists of seven optic fibres that can be independently coupled to laser sources of different wavelengths.
By feeding a single laser of a given wavelength to two different fibres, one can leverage the phenomenon of interference to project a 2D sinusoidal pattern onto the target tissue.
The spatial characteristics of the resulting pattern can be tuned by selecting different fibre pairs, and patterns consisting of up to three different wavelengths (such as green, red, and blue) can be projected simultaneously.
By combining this projection approach with an ultraminiature camera (1 mm x 1 mm), the researchers developed a prototype SFDI system with a diameter of just 3 mm.
Moreover, using a custom algorithm that tracks phase deviations in the projected sinusoidal patterns, they managed to reduce noise in the captured absorption and scattering profiles.
Experiments with tissue phantoms mimicking the optical properties of healthy and cancerous tissues showed that the proposed device could provide excellent contrast between the two tissue types.
More specifically, the specificity and sensitivity values for detecting squamous cell carcinoma were estimated to be over 90 percent, on par with the current clinical standards of medical devices.
The researchers remark that the proposed system could be miniaturized further to a diameter as small as 1.5 mm, allowing for minimally invasive endoscopic procedures.
Additionally, its compatibility with multiwavelength imaging (using lasers of different colours) implies that the system could be used to capture optical information at different tissue depths, enabling the analysis of multiple tissue layers at the same time.
Together, the findings of this study showcase the potential of this innovative imaging approach for diagnostic applications.
“Our prototype shows promise as a cost-effective, quantitative imaging tool to detect variations in optical absorption and scattering as indicators of cancer,” concludes Crowley.
“This work could form the basis of new devices suitable for cost-effective endoscopic deployment for screening of gastrointestinal cancers.”
Source: Spie - International Society for Optics and Photonics
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.